Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II–III esophageal carcinoma

M. Caro; Albert Font; Silvia Comas; Marta Viciano; Jordi Remón; P. Céliz; Juvencio Robles; Eva Musulen; Maria José Sendrós; E. Mesalles; J.J. Arenas-Jiménez; J. Boix; Adrián Ramírez-de-Arellano; J Fernández-Llamazares

doi:10.1007/s12094-016-1488-y

Related publications

Article2015

Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil

Kazuomi Ueshima, Masatoshi Kudo, Masatoshi Tanaka, Takashi Kumada, Hobyung Chung, Satoru Hagiwara, Tatsuo Inoue, Norihisa Yada, Satoshi Kitai

Article2016

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial

M. Ikeda, Satoshi Shimizu, Tosiya Sato, Manabu Morimoto, Yasushi Kojima, Yoshitaka Inaba, Atsushi Hagihara, Masatoshi Kudo, Shoji Nakamori, Shuichi Kaneko, Rie Sugimoto, T. Tahara, Takumi Ohmura, K. Yasui, Kiyoshi Sato, Hiroshi Ishii, Junji Furuse, Takuji Okusaka

Article2023

Multicenter Phase II Trial of Lenvatinib plus Hepatic Intra-Arterial Infusion Chemotherapy with Cisplatin for Advanced Hepatocellular Carcinoma: LEOPARD

Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Satoshi Shimizu, Yasushi Kojima, Atsushi Hiraoka, Kazuhiro Nouso, Hiroshi Aikata, Kazushi Numata, Tosiya Sato, Takuji Okusaka, Junji Furuse

Article2021

937P Multicenter phase II trial of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma: LEOPARD

Masafumi Ikeda, Tatsuya Yamashita, Sadahisa Ogasawara, Masatoshi Kudo, Yoshitaka Inaba, Manabu Morimoto, Kaoru Tsuchiya, Shinichi Shimizu, Yasushi Kojima, Atsushi Hiraoka, Kazuhiro Nouso, Hiroshi Aikata, Kazushi Numata, Tosiya Sato, Takuji Okusaka, Junji Furuse

Article2000

Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in Stage III and IV ovarian carcinoma

C.A. Papadimitriou, Lia A. Moulopoulos, Georgios Vlahos, Zannis Voulgaris, Evangelos Kiosses, Nikolaos Georgoulias, Dimitra Gika, Emmanuel Diakomanolis, Stylianos Michalas, Meletios A Dimopoulos